{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:39:24Z","timestamp":1791405564965,"version":"4.3.3"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":5236,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004769","name":"Universit\u00e0 degli Studi di Pavia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1046\/j.1523-1747.2001.01408.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T05:59:03Z","timestamp":1047448743000},"page":"326-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":184,"title":["Specific Cytotoxic T Lymphocyte Responses Against Melan-A\/MART1, Tyrosinase and Gp100 in Vitiligo by the Use of Major Histocompatibility Complex\/Peptide Tetramers: the Role of Cellular Immunity in the Etiopathogenesis of Vitiligo"],"prefix":"10.1016","volume":"117","author":[{"given":"Belinda","family":"Palermo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Campanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Garbelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Lantelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Brazzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ardig\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Martinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Badulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Necker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Giachino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"274","author":"Altman","year":"1996","journal-title":"Science"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0015","first-page":"177","article-title":"Synthetic antigenic peptides as a new strategy for immunotherapy of cancer","volume":"1","author":"Appella","year":"1995","journal-title":"Biomed Pept Proteins Nucleic Acids"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/path.1711690205","article-title":"Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo","volume":"169","author":"al Badri","year":"1993","journal-title":"J Pathol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.1711700209","article-title":"An immunohistological study of cutaneous lymphocytes in vitiligo","volume":"170","author":"al Badri","year":"1993","journal-title":"J Pathol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0140-6736(84)90084-9","article-title":"Antibodies to melanocytes in vitiligo","volume":"i","author":"Betterle","year":"1984","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0035","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0952-7915(97)80049-0","article-title":"Cancer tumor antigens","volume":"9","author":"Boon","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0040","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0738-081X(97)00126-0","article-title":"Immune mechanisms in vitiligo","volume":"15","author":"Bystryn","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0045","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1073\/pnas.92.18.8125","article-title":"Immunophenotyping of melanomas for tyrosinase: implications for vaccine development","volume":"92","author":"Chen","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0050","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12476636","article-title":"Cytolytic antibodies to melanocytes in vitiligo","volume":"100","author":"Cui","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0055","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archderm.1995.01690150078015","article-title":"Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells","volume":"131","author":"Cui","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0060","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.4049\/jimmunol.165.11.6644","article-title":"shift in the phenotype of Melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response","volume":"165","author":"Dunbar","year":"2000","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0065","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/40166","article-title":"Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells","volume":"389","author":"Fuhlbrigge","year":"1997","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12324456","article-title":"In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo","volume":"105","author":"Gilhar","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.176.2.553","article-title":"A fail-safe mechanism for maintaining self-tolerance","volume":"176","author":"Guerder","year":"1992","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0733-8635(05)70149-2","article-title":"New and emerging therapies for vitiligo","volume":"18","author":"Halder","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0085","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2133.1998.02550.x","article-title":"Vitiligo melanocytes in long-term culture show normal constitutive and cytokine-induced expression of intercellular adhesion molecule-1 and major histocompatibility complex class I and class II molecules","volume":"139","author":"Hedley","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0090","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4049\/jimmunol.164.2.596","article-title":"The use of HLA A2.1\/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire","volume":"164","author":"Hernandez","year":"2000","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0095","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00002371-199711000-00005","article-title":"Differential expression of MART-1 in primary and metastatic melanoma lesions","volume":"20","author":"Kageshita","year":"1997","journal-title":"J Immunother"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0092-8674(87)90568-X","article-title":"T cell tolerance by clonal elimination in the thymus","volume":"49","author":"Kappler","year":"1987","journal-title":"Cell"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1523-1747.ep12276556","article-title":"Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay","volume":"109","author":"Kemp","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0110","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1074-7613(00)80647-0","article-title":"High- and low-potency ligands with similar affinities for the TCR. the importance of kinetics in TCR signaling","volume":"9","author":"Kersh","year":"1998","journal-title":"Immunity"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0115","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/333742a0","article-title":"Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes","volume":"333","author":"Kisielow","year":"1988","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0120","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1074-7613(00)80009-6","article-title":"Thymic selection by a single MHC\/peptide ligand: autoreactive T cells are low-affinity cells","volume":"10","author":"Lee","year":"1999","journal-title":"Immunity"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/1074-7613(95)90170-1","article-title":"Low avidity recognition of self-antigen by T cells permits escape from central tolerance","volume":"3","author":"Liu","year":"1995","journal-title":"Immunity"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/346476a0","article-title":"Empty MHC class I molecules come out in the cold","volume":"346","author":"Ljunggren","year":"1990","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0140","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.184.2.647","article-title":"Identification of epitope mimics recognized by CTL reactive to the melanoma\/melanocyte-derived peptide MART-1 (27\u201335)","volume":"184","author":"Loftus","year":"1996","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1346-8138.1998.tb02472.x","article-title":"Peripheral T-cell activation in non-segmental vitiligo","volume":"25","author":"Mahmoud","year":"1998","journal-title":"J Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0150","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0738-081X(97)00132-6","article-title":"Non PUVA nonsurgical therapies for vitiligo","volume":"15","author":"Mandel","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00002371-199605000-00004","article-title":"Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in situ lesions","volume":"19","author":"Marincola","year":"1996","journal-title":"J Immunother"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0160","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000421-199612000-00017","article-title":"Melanoma-associated hypopigmentation: Where are the antibodies?","volume":"19","author":"Merimsky","year":"1996","journal-title":"Am J Clin Oncol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02737633","article-title":"The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions","volume":"16","author":"Merimsky","year":"1998","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4049\/jimmunol.160.2.643","article-title":"Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity","volume":"160","author":"Morgan","year":"1998","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0175","series-title":"Fitzpatrick's Dermatology in General Medicine","first-page":"945","article-title":"Hypomelanoses and Hypermelanoses","author":"Mosher","year":"1999"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.158.1.246","article-title":"Antibodies to normal human melanocytes in vitiligo","volume":"158","author":"Naughton","year":"1983","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0185","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0190","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1399-0039.1993.tb01991.x","article-title":"HLA-DQB1 and DQA1 typing by PCR amplification with sequence specific primers PCR-SSP in two hours","volume":"41","author":"Olerup","year":"1993","journal-title":"Tissue Antigens"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0200","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/1521-4141(200102)31:2<412::AID-IMMU412>3.0.CO;2-4","article-title":"Diverse expansion potential and heterogeneous avidity in tumor-associated antigen-specific T lymphocytes from primary melanoma patients","volume":"31","author":"Palermo","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0205","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.157.6.2539","article-title":"Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues","volume":"157","author":"Parkhurst","year":"1996","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0210","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.190.5.705","article-title":"High frequencies of naive Melan-A\/MART1-specific CD8+ T cells in a large proportion of human histocompatibility leukocyte antigen (HLA) -A2 individuals","volume":"190","author":"Pittet","year":"1999","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0215","first-page":"469","article-title":"PUVA-therapy and association of phenylalanine and UVA-therapy in vitiligo. A multicenter-study of 81 observations","volume":"2","author":"Pruvot-Sentous","year":"1992","journal-title":"Euro J Derm"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0220","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(94)91709-4","article-title":"The role of tyrosinase in autoimmune vitiligo","volume":"344","author":"Song","year":"1994","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0225","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/372100a0","article-title":"T-cell apoptosis detected in situ during positive and negative selection in the thymus","volume":"372","author":"Surh","year":"1994","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0230","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.4049\/jimmunol.160.4.1750","article-title":"Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A\/MART-1 immunodominant peptide analogues","volume":"160","author":"Valmori","year":"1998","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0235","first-page":"2167","article-title":"An antigen-targeted approach to adoptive transfer therapy of cancer","volume":"59","author":"Valmori","year":"1999","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0240","first-page":"4050","article-title":"Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368\u2013376","volume":"59","author":"Valmori","year":"1999","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0245","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0952-7915(97)80050-7","article-title":"T cell defined tumor antigens","volume":"9","author":"Van den Eynde","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0250","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/eji.1830240340","article-title":"Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes","volume":"24","author":"Van Wolfel","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0255","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1084\/jem.190.7.983","article-title":"The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope","volume":"190","author":"Wang","year":"1999","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01408.x_bb0260","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1084\/jem.189.10.1531","article-title":"A kinetic threshold between negative and positive selection based on the longevity of the T cell receptor-ligand complex","volume":"189","author":"Williams","year":"1999","journal-title":"J Exp Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15413314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15413314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T23:05:19Z","timestamp":1682118319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15413314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0022202X15413314"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1747.2001.01408.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific Cytotoxic T Lymphocyte Responses Against Melan-A\/MART1, Tyrosinase and Gp100 in Vitiligo by the Use of Major Histocompatibility Complex\/Peptide Tetramers: the Role of Cellular Immunity in the Etiopathogenesis of Vitiligo","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1523-1747.2001.01408.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 The Society for Investigative Dermatology, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}